54 studies found for:    "hereditary angioedema"
Show Display Options
Rank Status Study
1 Not yet recruiting Study to Assess the Tolerability and Safety of Ecallantide in Children and Adolescents With Hereditary Angioedema
Condition: Hereditary Angioedema Types I and II
Intervention: Drug: Ecallantide subcutaneous dosing
2 Recruiting A Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema
Condition: Hereditary Angioedema Types I and II
Interventions: Biological: Low-volume C1-esterase inhibitor;   Biological: Higher-volume C1-esterase inhibitor;   Biological: Low-volume placebo;   Biological: Higher-volume placebo
3 Recruiting A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema
Condition: Hereditary Angioedema
Intervention: Drug: icatibant
4 Completed Pharmacokinetics of C1 Esterase Inhibitor in Hereditary Angioedema Subjects
Condition: Hereditary Angioedema
Intervention: Drug: C1 esterase inhibitor [human] (C1INH-nf)
5 Recruiting Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients
Condition: Hereditary Angioedema
Intervention: Drug: rhC1INH
6 Completed
Has Results
Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks
Condition: Hereditary Angioedema
Intervention: Biological: C1 esterase inhibitor [human] (C1INH-nf)
7 Completed
Has Results
Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks
Condition: Hereditary Angioedema
Intervention: Biological: C1 esterase inhibitor [human] (C1INH-nf)
8 Completed
Has Results
Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema
Conditions: Hereditary Angioedema;   Angioneurotic Edema;   Genetic Disorders
Interventions: Drug: recombinant human C1 inhibitor;   Drug: Placebo
9 Completed
Has Results
Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema
Conditions: Hereditary Angioedema;   Angioneurotic Edema
Interventions: Drug: Recombinant Human C1 Inhibitor;   Drug: placebo
10 Withdrawn Study to Evaluate Ecallantide in Paediatric Patients With Acute Attacks of Hereditary Angioedema
Condition: Hereditary Angioedema
Intervention: Biological: ecallantide
11 Recruiting Safety and Efficacy Study of CINRYZE for Prevention of Angioedema Attacks in Children Ages 6-11 With Hereditary Angioedema
Condition: Hereditary Angioedema
Intervention: Biological: CINRYZE
12 Recruiting A European Post-Authorisation Observational Study Of Patients With Hereditary Angioedema
Condition: Hereditary Angioedema
Intervention:
13 Completed Efficacy, Safety and Tolerability of a Self-Administered Subcutaneous Formulation of Icatibant for the Treatment of Acute Attacks of Hereditary Angioedema
Condition: Hereditary Angioedema
Intervention: Drug: Icatibant
14 Completed
Has Results
CINRYZE for the Treatment of Hereditary Angioedema Attacks in Children Under the Age of 12
Condition: Hereditary Angioedema
Intervention: Biological: CINRYZE
15 Completed
Has Results
Efficacy Study of DX-88 (Ecallantide) to Treat Acute Attacks of Hereditary Angioedema (HAE)
Condition: Hereditary Angioedema
Interventions: Drug: ecallantide;   Drug: Phosphate Buffer Saline (PBS), pH 7.0
16 Completed
Has Results
Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema (HAE)
Condition: Hereditary Angioedema
Interventions: Drug: Icatibant;   Drug: Tranexamic Acid;   Drug: Oral Placebo;   Drug: S.C. Placebo
17 Completed
Has Results
Safety and Efficacy Study of Repeated Doses of DX-88 (Ecallantide) to Treat Attacks of Hereditary Angioedema (HAE)
Condition: Hereditary Angioedema
Intervention: Drug: ecallantide
18 Completed A Study of Icatibant in Patients With Acute Attacks of Hereditary Angioedema (FAST-3)
Condition: Hereditary Angioedema
Interventions: Drug: Icatibant;   Drug: Placebo
19 Recruiting Double-Blind, Multiple Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of DX-2930 in Hereditary Angioedema Subjects
Condition: Hereditary Angioedema
Interventions: Drug: DX-2930;   Drug: Placebo
20 Completed
Has Results
Efficacy and Safety Study of DX-88 to Treat Acute Attacks of Hereditary Angioedema (HAE)
Condition: Hereditary Angioedema (HAE)
Interventions: Drug: ecallantide;   Drug: Phosphate Buffer Saline (PBS),

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years